Shape the Future of Precision Transplantation:
ILTS Consensus 2026 will set global benchmarks for biomarker validation, regulatory adoption, and clinical integration in liver transplantation. For pharmaceutical and diagnostics companies developing immunosuppressive agents, molecular diagnostics, or digital tools, this is a rare opportunity to engage with key leaders shaping the clinical pathways your products will enter.
Gain High-Impact Visibility with Global Key Opinion Leaders:
This exclusive, consensus-driven forum will gather over 100 of the world’s top transplant surgeons, hepatologists, pathologists, scientists and innovators.
Align with Evidence-Based Innovation:
ILTS is the largest international society in liver transplantation, uniquely positioned to disseminate findings into clinical guidelines, educational platforms, and policy. Supporting this meeting ties your brand to rigorous, peer-reviewed, and clinically relevant science with global reach.
Leverage Multi-Stakeholder Networking:
The meeting brings together not just clinicians and researchers, but also regulators, payers, patient advocates, and digital health experts. Supporting partners will have access to a diverse and influential audience, accelerating partnership, co-development, and real-world application.
Accelerate Access and Adoption:
By supporting a meeting focused on consensus and standardization, your company helps build the frameworks that speed clinical trial design, biomarker qualification, regulatory alignment, and payer engagement – critical steps for faster market entry and real-world impact.
SECURE YOUR SPONSORSHIP NOW !
DISCOVER – a variety of sponsorship, exhibition and advertising opportunities on the following pages. SELECT – a sponsorship level and review the full list of exclusive entitlements. ADD-ONS & ADVERTISING – enhance your sponsorship with additional properties, venue and/or digital advertising. CUSTOMIZE – suggest amendments and/or unique activations. – SECURE your sponsorship now by contacting the ILTS Consensus 2026 Secretariat: karen.seto@wearemci.com.
